This regulatory hierarchy aligns with established LOXL2-PI3K/AKT pathway crosstalk documented across multiple cancer types (Tan et al., 2025; S. Wu et al., 2021; J. Yang et al., 2016). The gene discussed is LOXL2; the disease is cancer.